Neurology Specific Literature Search   
 
[home][thesaurus]
    

Enter your terms
above and click
the 'Search' button.
Showing articles 0 to 13 of 13

Filter Applied: risk-benefit assessment (Click to remove)

Antiplatelet and Anticoagulant Risk for Select Spine Interventions:A Retrospective Cohort
Pain Med 21:910-917, Ehsanian,R.,et al, 2020

Management of Sciatica
NEJM 376:1175-1177, Ramaswami, Ramya, 2017

Systematic Review: Efficacy and Safety of Medical Marijuana in Selected Neurologic Disorders
Neurol 82:1556-1563, Koppel, B.S.,et al, 2014

Should Statins be Paused or Discontinued After Thrombolysis or Acute Intracerebral Hemorrhage? No!
Stroke 44:1472-1476, Scheitz, J.F.,et al, 2013

Weighing the Benefits of High-Dose Simvastatin against the Risk of Myopathy
NEJM 365:285-287, Egan, A.,et al, 2011

A Systematic Review of Antiepilpetic Drug Initiation and Withdrawal
The Neurologist 15:122-131, Shih,J.J &Ochoa,J.G., 2009

Back Surgery -- Who Needs It?
NEJM 356:2239-2245, Deyo,R.A., 2007

Surgical Versus Nonsurgical Treatment for Back Pain
NEJM 357:1255, Copeland,B., 2007

Practice Parameter: Treatment of the Child with a First Unprovoked Seizure
Neurol 60:166-175, Hirtz,D.,et al, 2003

Continuation of Medically Necessary Aspirin and Warfarin During Cutaneous Surgery
Mayo Clin Proc 78:1392-1396, Otley,C.C., 2003

The Risk-Benefit Profile of Commonly Used Herbal Therapies: Ginkgo, St. John's Wort, Genseng, Echinacea, Saw Palmetto, and Kava
Ann Int Med 136:42-53, Ernst,E., 2002

Is There a Neurologist on the Flight?
Neurol 58:1739-1744,1717, Sirven,J.I.,et al, 2002

When to Start and Stop Anticonvulsant Therapy in Children
Arch Neurol 56:1073-1077, Greenwood,R.S.&Tennison,M.B., 1999



Showing articles 0 to 13 of 13